Long-Term Follow-Up of R-CHOP and Rituximab Maintenance in Elderly Patients With Mantle Cell Lymphoma
Long-term follow-up confirmed preliminary results suggesting that rituximab maintenance following treatment with R-CHOP is safe and effective.
Long-term follow-up confirmed preliminary results suggesting that rituximab maintenance following treatment with R-CHOP is safe and effective.
Researchers conducted an assessment of end-of-life care and the effects of care practices on costs for patients with CRC in the United States and in Canada.
This study found that many rural-living patients with colorectal or cervical cancer may have to travel significantly greater distances to reach a cancer specialist than urban dwellers.
Clinic visits and care conversations guided by a geriatric assessment better addressed patient and caregiver concerns, particularly regarding cognition and functionality.
This “Clinical Picture” describes a case of extramedullary multiple myeloma manifesting as a rapidly growing intraoral lesion.
Using personal experience as a catalyst, this author conducted a literature study to determine how marital status influences recommendations regarding cancer therapy.
The TEAMM trial sought to assess time to first febrile episode or death from all causes in patients with newly diagnosed myeloma who received antibiotic prophylaxis vs those who did not.
Patients referred to the clinic were diagnosed nearly 2 weeks faster compared with historical controls.
Disparities between NCCN guideline-concordant treatment and actual care were most likely to occur in two patient populations.
Exercise tolerance was found to be associated with verbal fluency, dominant motor speed, and math academics, among other neurocognitive metrics.